Legal & General Group PLC Axsome Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 36,873 shares of AXSM stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,873
Previous 36,873 -0.0%
Holding current value
$3.2 Million
Previous $3.31 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$78.93 - $95.84 $48,463 - $58,845
614 Added 1.69%
36,873 $3.31 Million
Q2 2024

Aug 14, 2024
BUY
$65.72 - $80.5 $222,922 - $273,056
3,392 Added 10.32%
36,259 $2.92 Million
Q1 2024

May 14, 2024
SELL
$69.39 - $97.64 $10,408 - $14,646
-150 Reduced 0.45%
32,867 $2.62 Million
Q4 2023

Feb 15, 2024
SELL
$57.42 - $83.61 $50,701 - $73,827
-883 Reduced 2.6%
33,017 $2.63 Million
Q3 2023

Nov 14, 2023
BUY
$69.25 - $82.21 $39,888 - $47,352
576 Added 1.73%
33,900 $2.37 Million
Q2 2023

Aug 14, 2023
BUY
$58.41 - $90.35 $156,305 - $241,776
2,676 Added 8.73%
33,324 $2.39 Million
Q1 2023

May 15, 2023
BUY
$58.39 - $75.0 $212,364 - $272,775
3,637 Added 13.46%
30,648 $1.89 Million
Q4 2022

Feb 14, 2023
BUY
$39.94 - $79.72 $9,985 - $19,930
250 Added 0.93%
27,011 $2.08 Million
Q3 2022

Nov 14, 2022
SELL
$36.06 - $69.85 $63,862 - $123,704
-1,771 Reduced 6.21%
26,761 $1.19 Million
Q2 2022

Aug 22, 2022
BUY
$21.74 - $46.75 $130,157 - $279,892
5,987 Added 26.56%
28,532 $1.09 Million
Q1 2022

May 16, 2022
SELL
$23.7 - $41.39 $331 - $579
-14 Reduced 0.06%
22,545 $933,000
Q4 2021

Feb 14, 2022
BUY
$30.7 - $43.36 $1,842 - $2,601
60 Added 0.27%
22,559 $852,000
Q3 2021

Nov 15, 2021
BUY
$19.91 - $68.26 $94,612 - $324,371
4,752 Added 26.78%
22,499 $741,000
Q2 2021

Aug 12, 2021
SELL
$50.63 - $73.5 $8,404 - $12,201
-166 Reduced 0.93%
17,747 $1.2 Million
Q1 2021

May 17, 2021
BUY
$55.91 - $81.44 $113,553 - $165,404
2,031 Added 12.79%
17,913 $1.01 Million
Q4 2020

Feb 12, 2021
SELL
$66.31 - $86.52 $5,437 - $7,094
-82 Reduced 0.51%
15,882 $1.29 Million
Q3 2020

Nov 13, 2020
SELL
$68.34 - $85.84 $83,374 - $104,724
-1,220 Reduced 7.1%
15,964 $1.14 Million
Q2 2020

Aug 14, 2020
BUY
$49.87 - $98.69 $9,425 - $18,652
189 Added 1.11%
17,184 $1.41 Million
Q1 2020

May 14, 2020
BUY
$41.2 - $101.31 $373,601 - $918,679
9,068 Added 114.39%
16,995 $1 Million
Q4 2019

Feb 13, 2020
BUY
$16.71 - $106.24 $44,966 - $285,891
2,691 Added 51.39%
7,927 $820,000
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $70,476 - $134,827
5,236 New
5,236 $135,000

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.72B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email